Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trial.
Schofield P, Juraskova I, Bergin R, Gough K, Mileshkin L, Krishnasamy M, White K, Bernshaw D, Penberthy S, Aranda S. Schofield P, et al. Among authors: mileshkin l. Trials. 2013 Feb 11;14:39. doi: 10.1186/1745-6215-14-39. Trials. 2013. PMID: 23399476 Free PMC article. Clinical Trial.
A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocol.
Philip J, Collins A, Le B, Sundararajan V, Brand C, Hanson S, Emery J, Hudson P, Mileshkin L, Ganiatsas S. Philip J, et al. Among authors: mileshkin l. Pilot Feasibility Stud. 2019 Mar 14;5:44. doi: 10.1186/s40814-019-0424-7. eCollection 2019. Pilot Feasibility Stud. 2019. PMID: 30915228 Free PMC article.
First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers.
Scott AM, Akhurst T, Lee FT, Ciprotti M, Davis ID, Weickhardt AJ, Gan HK, Hicks RJ, Lee ST, Kocovski P, Guo N, Oh M, Mileshkin L, Williams S, Murphy D, Pathmaraj K, O'Keefe GJ, Gong SJ, Pedersen JS, Scott FE, Wheatcroft MP, Hudson PJ. Scott AM, et al. Among authors: mileshkin l. Theranostics. 2020 Sep 15;10(25):11404-11415. doi: 10.7150/thno.49422. eCollection 2020. Theranostics. 2020. PMID: 33052222 Free PMC article. Clinical Trial.
Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards.
Segelov E, Carrington C, Aranda S, Currow D, Zalcberg JR, Heriot AG, Mileshkin L, Coutsouvelis J, Millar JL, Collopy BT, Emery JD, Zhang P, Cooper S, O'Kane C, Wale J, Hancock SJ, Sulkowski A, Bashford J. Segelov E, et al. Among authors: mileshkin l. Med J Aust. 2021 Jun;214(11):528-531. doi: 10.5694/mja2.51087. Epub 2021 May 30. Med J Aust. 2021. PMID: 34053081 Review.
313 results